cloud platforms

Views & Analysis

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.